What happened to Babylon Health after reaching $1bn+ revenue? And how Ali Parsa is continuing his mission to fix healthcare for all with AI startup Quadrivia.
Ali Parsa delivers a brutally honest postmortem of Babylon Health's spectacular rise to $1bn+ revenue and equally dramatic collapse, arguing that operational excellence wasn't enough to overcome fundamental financing missteps. He makes a compelling case that AI can finally solve healthcare's supply shortage by automating the routine clinical tasks that doctors actually dislike, while candidly addressing the trust and safety concerns that could make or break medical AI adoption.
Key takeaways
- •Growing at 400% annually is 'incredibly hard' according to someone who actually did it, challenging VCs who demand hyper-growth without operational experience.
- •Healthcare suffers from artificial scarcity where rushed doctors can't meet patient demand, creating systematic dissatisfaction on both sides.
- •AI can create 'abundance of clinical supply' by automating 20-40% of routine clinical tasks that practitioners find repetitive and dislike.
- •Operational success and massive revenue growth can still lead to company failure if financing strategy is fundamentally flawed.
Listen to full episode
Best moment
I grew Babylon 400% a year, and I can tell you it's incredibly, incredibly hard to go at that rate continuously. The VCs who are saying this kind of stuff, if you look at the guys who are talking about it, they have never run a business.
“The VCs who are saying this kind of a stuff, if you look at the guys who are talking about it, they have never run a business on them.”
hundreds and hundreds of percentage a year, you're not growing. Right? I mean, I grew Babylon 400% a year, and I can tell you it's incredibly, incredibly hard to go at that rate continuously. Right? I promise you this. The VCs who are saying this kind of a stuff, if you look at the guys who are talking about it, they have never run a business on them.
3 clips
Ordered by timestamp. Jump to the moment you care about.
Related episodes
20VC: Anthropic Wipes Billions Off Markets | Citrini Research: The Ultimate Breakdown: Agents, "Ghost GDP", Consumer Spend etc. | Figma Earnings Beat & Four Public Stocks to Buy | Jack Altman Joins Benchmark
The Twenty Minute VC (20VC) · Jack Altman Joins Benchmark · Feb 26, 2026
Behind the Scenes with an early OpenClaw contributor! | E2252
This Week in Startups · Feb 26, 2026
E702 | Lubomila Jordanova, Plan A: Climate Isn’t “Over”
EUVC · Feb 25, 2026
Kill Your Startup’s Knowledge Chaos with OpenClaw (with Oliver Henry and Jeff Weisbein) | E2254
This Week in Startups · Feb 24, 2026
From the blog
Want clips like this for your podcast?
We find your top 5-8 clips, write the hooks, and deliver ready-to-post content. First 2 episodes are free.
Get 2 Episodes Clipped Free